United States Allergy Market Insight
Published: 04 June 2026 | Report Format: Electronic (PDF)
The United States Allergy Market will grow at a rate of 6.52% due to the rising prevalence of food, respiratory, and skin allergies, increasing adoption of advanced diagnostic technologies, growing awareness regarding allergy management, and expanding demand for immunotherapy and personalized treatment solutions
United States Allergy Market Insights Forecasts to 2035
- The United States Allergy Market Size Was Estimated USD 11.6 Billion in 2025.
- The Market Size is Expected to Grow at a CAGR of around 6.52% from 2025 to 2035.
- The United States Allergy Market Size is Expected to rise around USD 21.8 Billion by 2035.
Notable Insights for the United States Allergy Market
• Segmentation on the basis of Product Type indicates that Allergy Therapeutics & Immunotherapy Solutions segment holds the dominant position in the United States Allergy Market in 2025 with a market share of nearly 57% due to increasing use of antihistamines, biologics, epinephrine products, and allergy immunotherapy treatments.
• Segmentation on the basis of Application indicates that Food Allergy, Respiratory Allergy & Allergic Rhinitis application segment holds the dominant position in the United States Allergy Market in 2025 with a market share of around 61% due to the growing prevalence of allergic conditions and rising demand for long-term disease management solutions.
• World-wide projected revenue of Thermo Fisher Scientific Inc. in fiscal year 2025 would be around USD 43 billion, owing to high demand for allergy diagnostics, laboratory testing systems, and healthcare technology solutions.
Download the eBook (ToC)
• It is expected that increasing adoption of molecular diagnostics, precision medicine, and AI-enabled allergy testing platforms would contribute in driving the growth of the market, where advanced allergy diagnostic technologies improve detection accuracy by up to 41% and reduce testing turnaround times by nearly 28%.
Why Buy This Report
• Gives an in-depth analysis of the impact of trends in allergy diagnostics, immunotherapy development, personalized medicine, and healthcare digitalization on the United States Allergy Market growth.
• Provides strategic insights regarding technology innovation such as AI-based allergy diagnostics, molecular allergen testing technologies, digital patient monitoring systems, and precision immunotherapy solutions.
• Assists players to analyze competitive benchmarking, investment in healthcare diagnostics, expansion in allergy treatment services, and research initiatives by major healthcare and pharmaceutical companies.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Allergy Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Allergy Market
• Thermo Fisher Scientific Inc.
• Stallergenes Greer
• ALK-Abelló A/S
• Sanofi S.A.
• Pfizer Inc.
• Merck & Co., Inc.
• AbbVie Inc.
• Siemens Healthineers AG
• Danaher Corporation
• BioMérieux SA
Recent Developments:
• In February 2025, Stallergenes Greer expanded the U.S. launch of Palforzia for children aged 1–3 years with peanut allergy, supporting early allergy intervention and treatment management.
• In April 2025, Thermo Fisher Scientific Inc. expanded access to advanced allergy testing technologies and molecular diagnostic solutions to improve allergy detection and clinical decision-making.
Market Segmentation:
United States Allergy Market, By Product Type
• Allergy Diagnostics
• Allergy Therapeutics
• Immunotherapy Solutions
• Antihistamines
• Epinephrine Auto-Injectors
United States Allergy Market, By Technology
• AI-Based Allergy Diagnostic Systems
• Molecular Allergen Testing Technologies
• Precision Immunotherapy Platforms
• Digital Patient Monitoring Systems
• Automated Laboratory Diagnostic Solutions
United States Allergy Market, By Application
• Food Allergy
• Respiratory Allergy
• Allergic Rhinitis
• Skin Allergy & Dermatological Conditions
• Drug Allergy Testing
Expert Views:
The market for allergies in the United States is going to get bigger because more people are getting allergies. People are also becoming more aware of their health. They want better ways to diagnose and treat allergies. Allergies are a problem and people want to find new ways to deal with them. The market for allergies will get a boost from technologies like artificial intelligence that helps doctors diagnose allergies and molecular allergen testing that finds out what people are allergic to. There are also treatments like precision immunotherapy that can help people with allergies. Doctors and hospitals will use these technologies to make their work easier and to give people better care. This means that hospitals, diagnostic laboratories and specialty healthcare centers will see more people coming in for allergy diagnosis and treatment services because of these technologies like artificial intelligence-based diagnostic platforms and digital healthcare monitoring systems. The market, for allergies will keep growing because allergies are a problem and people want to find new ways to deal with them.
Author: Govind and Krishna By Spherical Insights and Consulting